Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia

Neuroscience Bulletin

Volumn 31, Issue 5, 2015, Pages 550-560

  Cai, Hongxia ^a,b   Mu, Zhihao ^a,b   Jiang, Zhen ^a,b   Wang, Yongting ^b   Yang, Guo Yuan ^a,b   Zhang, Zhijun ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

blood brain barrier; hypoxia response element; matrix metalloproteinase 9; stroke

Indexed keywords

GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LENTIVIRUS VECTOR; TIGHT JUNCTION PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; MMP9 PROTEIN, HUMAN; SB 3CT COMPOUND; SINGLE HETEROCYCLIC RINGS; SULFONE;

ADULT; ANIMAL CELL; ARTICLE; ASTROCYTE; BEHAVIOR; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME STRUCTURE; GENE OVEREXPRESSION; HYPOXIA; HYPOXIA RESPONSE ELEMENT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; MOUSE; NERVE CELL; NONHUMAN; PROMOTER REGION; ROTAROD TEST; TIGHT JUNCTION; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; VIRAL GENE THERAPY; ZYMOGRAPHY; ANIMAL; ATROPHY; CONVALESCENCE; DNA RESPONSIVE ELEMENT; GENE VECTOR; HEK293 CELL LINE; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LENTIVIRINAE; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY;

ANIMALS; ATROPHY; BLOOD-BRAIN BARRIER; GENETIC VECTORS; HEK293 CELLS; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-ISCHEMIA, BRAIN; LENTIVIRUS; MATRIX METALLOPROTEINASE 9; MICE; MOTOR ACTIVITY; RECOVERY OF FUNCTION; RESPONSE ELEMENTS; ROTAROD PERFORMANCE TEST; SULFONES; TIGHT JUNCTIONS;

EID: 84942365949     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-015-1533-1     Document Type: Article

References (43)

1. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007, 87: 179–197.
2. Tang Y, Cai B, Yuan F, He X, Lin X, Wang J, et al. Melatonin pretreatment improves the survival and function of transplanted mesenchymal stem cells after focal cerebral ischemia. Cell Transplant 2014, 23: 1279–1291.
3. Lu H, Wang Y, He X, Yuan F, Lin X, Xie B, et al. Netrin-1 hyperexpression in mouse brain promotes angiogenesis and long-term neurological recovery after transient focal ischemia. Stroke 2012, 43: 838–843.
4. Liu Y, Tang G, Li Y, Wang Y, Chen X, Gu X, et al. Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion. J Neuroinflammation 2014, 11: 177.
5. Clark KR, Johnson PR. Gene delivery of vaccines for infectious disease. Curr Opin Mol Ther 2001, 3: 375–384.
6. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003, 4: 346–358.
7. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004, 16: 558–564.
8. Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009, 8: 205–216.
9. Planas AM, Sole S, Justicia C. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis 2001, 8: 834–846.
10. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002, 297: 1186–1190.
11. Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, et al. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009, 29: 1179–1184.
12. Ferguson TA, Muir D. MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol Cell Neurosci 2000, 16: 157–167.
13. Larsen PH, Wells JE, Stallcup WB, Opdenakker G, Yong VW. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J Neurosci 2003, 23: 11127–11135.
14. Liu XS, Zhang ZG, Zhang RL, Gregg S, Morris DC, Wang Y, et al. Stroke induces gene profile changes associated with neurogenesis and angiogenesis in adult subventricular zone progenitor cells. J Cereb Blood Flow Metab 2007, 27: 564–574.
15. Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 2006, 12: 441–445.
16. Yong VW, Power C, Forsyth P, Edwards DR. Metallo proteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001, 2: 502–511.
17. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998, 21: 75–80.
18. Morancho A, Hernandez-Guillamon M, Boada C, Barcelo V, Giralt D, Ortega L, et al. Cerebral ischaemia and matrix metalloproteinase-9 modulate the angiogenic function of early and late outgrowth endothelial progenitor cells. J Cell Mol Med 2013, 17: 1543–1553.
19. Tu XK, Yang WZ, Liang RS, Shi SS, Chen JP, Chen CM, et al. Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Neurochem Res 2011, 36: 2022–2028.
20. Su H, Arakawa-Hoyt J, Kan YW. Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci U S A 2002, 99: 9480–9485.
21. Dong H, Wang Q, Zhang Y, Jiang B, Xu X, Zhang Z. Angiogenesis induced by hVEGF165 gene controlled by hypoxic response elements in rabbit ischemia myocardium. Exp Biol Med (Maywood) 2009, 234: 1417–1424.
22. Su H, Joho S, Huang Y, Barcena A, Arakawa-Hoyt J, Grossman W, et al. Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts. Proc Natl Acad Sci U S A 2004, 101: 16280–16285.
23. Tiscornia G, Singer O, Verma IM. Production and purification of lentiviral vectors. Nat Protoc 2006, 1: 241–245.
24. He X, Li Y, Lu H, Zhang Z, Wang Y, Yang GY. Netrin-1 overexpression promotes white matter repairing and remodeling after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2013, 33: 1921–1927.
25. Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY, et al. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 2005, 25: 6401–6408.
26. McColl BW, Rothwell NJ, Allan SM. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci 2008, 28: 9451–9462.
27. Liu H, Shubayev VI. Matrix metalloproteinase-9 controls proliferation of NG2+ progenitor cells immediately after spinal cord injury. Exp Neurol 2011, 231: 236–246.
28. Gyenge M, Amagase K, Kunimi S, Matsuoka R, Takeuchi K. Roles of pro-angiogenic and anti-angiogenic factors as well as matrix metalloproteinases in healing of NSAID-induced small intestinal ulcers in rats. Life Sci 2013, 93: 441–447.
29. Chen C, Lin X, Wang J, Tang G, Mu Z, Chen X, et al. Effect of HMGB1 on the paracrine action of EPC promotes postischemic neovascularization in mice. Stem Cells 2014, 32: 2679–2689.
30. Huang J, Li Y, Tang Y, Tang G, Yang GY, Wang Y. CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice. Stroke 2013, 44: 190–197.
31. Tang G, Liu Y, Zhang Z, Lu Y, Wang Y, Huang J, et al. Mesenchymal stem cells maintain blood-brain barrier integrity by inhibiting aquaporin-4 upregulation after cerebral ischemia. Stem Cells 2014, 32: 3150–3162.
32. Li Y, Huang J, He X, Tang G, Tang YH, Liu Y, et al. Postacute stromal cell-derived factor-1alpha expression promotes neurovascular recovery in ischemic mice. Stroke 2014, 45: 1822–1829.
33. Li Y, Chopp M, Chen J, Wang L, Gautam SC, Xu YX, et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 2000, 20: 1311–1319.
34. Yagi K, Kitazato KT, Uno M, Tada Y, Kinouchi T, Shimada K, et al. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator. Stroke 2009, 40: 626–631.
35. Fan Y, Shen F, Frenzel T, Zhu W, Ye J, Liu J, et al. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 2010, 67: 488–497.
36. Montaner J, Alvarez-Sabin J, Molina C, Angles A, Abilleira S, Arenillas J, et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 2001, 32: 1759–1766.
37. Turner NA, Aley PK, Hall KT, Warburton P, Galloway S, Midgley L, et al. Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms. J Mol Cell Cardiol 2007, 43: 168–176.
38. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998, 10: 602–608.
39. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 2005, 169: 681–691.
40. Ruan H, Su H, Hu L, Lamborn KR, Kan YW, Deen DF. A hypoxia-regulated adeno-associated virus vector for cancerspecific gene therapy. Neoplasia 2001, 3: 255–263.
41. Xu ZL, Mizuguchi H, Ishii-Watabe A, Uchida E, Mayumi T, Hayakawa T. Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene 2001, 272: 149–156.
42. Dawson MR, Polito A, Levine JM, Reynolds R. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 2003, 24: 476–488.
43. Li J, Siegel M, Yuan M, Zeng Z, Finnucan L, Persky R, et al. Estrogen enhances neurogenesis and behavioral recovery after stroke. J Cereb Blood Flow Metab 2011, 31: 413–425.